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Abstract Both glycosylated amyloidogenic lysozymes I55T/
G49N and D66H/G49N were expressed in wild-type and
calnexin-disrupted Saccharomyces cerevisiae. The secretion
amounts of mutant I55T/G49N were almost similar in both
wild-type and calnexin-disrupted S. cerevisiae. In contrast, the
secretion of mutant D66H/G49N greatly increased in calnexin-
disrupted S. cerevisiae, while the secretion was very low in the
wild-type strain. In parallel, the induction level of the molecular
chaperones BiP and PDI located in the endoplasmic reticulum
(ER) was investigated when these glycosylated amyloidogenic
lysozymes were expressed in wild-type and calnexin-disrupted
S. cerevisiae. The mRNA concentrations of BiP and PDI were
evidently increased when mutant lysozyme D66H/G49N was
expressed in calnexin-disrupted S. cerevisiae, while they were
not so increased when I55T/G49N mutant was expressed. This
observation indicates that the conformation of mutant lysozyme
D66H/G49N was less stable in the ER, thus leading to the
higher-level expression of ER molecular chaperones via the
unfolded protein response pathway. This suggests that glycosy-
lated amyloidogenic lysozyme I55T/G49N may have a relatively
stable conformation in the ER, thus releasing it from the quality
control of calnexin compared with mutant lysozyme D66H/
G49N. ß 2002 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The endoplasmic reticulum (ER) quality control system is
extremely important to the eukaryotic organism which retains
misfolded intermediates in the ER until these substrates fold
properly or until the misfolded proteins are degraded [1^3]. It
seems likely that the stable conformation of the nascent pro-
tein in the ER leads it to the secretion pathway and the un-
stable conformation of the nascent protein leads it to the
degradation pathway [4]. The lowering of the function of
the ER quality control system usually leads the organism to
su¡ering the over-expression of misfolded proteins which may
result in serious diseases. Calnexin is a component of the ER
quality control system through its oligosaccharide moieties for
glycoproteins [3]. Interestingly, disruption of the calnexin gene
leads to the deletion of ER quality control for glycoproteins
but does not a¡ect the normal growth of Saccharomyces ce-
revisiae [4,5]. Thus, wild-type and calnexin-disrupted S. cere-
visiae were used as model strains with and without ER quality
control, respectively.
It has been reported that the two naturally occurring hu-
man lysozyme variants were both amyloidogenic, causing au-
tosomal dominant hereditary amyloidosis [6]. The two natural
mutations are heterozygous for the single base changes which
encode non-conservative amino acid substitutions, Ile56Thr
and Asp67His, respectively [6]. Ile56 is the pivotal residue
for the structural integrity of the lysozyme fold in that it links
the two domains. Its importance is emphasized by its high
conservation in the lysozyme sequences [7,8]. Substitution of
Asp67 with histidine destroys the network of hydrogen bonds
that stabilizes the L domain, resulting in a large and concerted
movement of the L sheet and the long loop within the
L domain away from each other. Interestingly, the crystal struc-
ture of variant I56T is similar to that of wild-type lysozymes [6].
This is presumably due to the fact that the hydrogen-
bonding potential of the hydrophilic side chain is partly sat-
is¢ed by a hydrogen bond to one of the water molecules
found in both the wild-type and the variant structures, even
though its hydrophilic side chain is in an unfavorable hydro-
phobic environment [6]. We have reported in a previous paper
that the mutant hen lysozymes Ile55Thr and Asp66His, cor-
responding to human amyloidogenic mutant lysozymes
Ile56Thr and Asp67His, respectively, were secreted in the
yeast S. cerevisiae and that glycosylated amyloidogenic hen
egg white lysozymes I55T/G49N and D66H/G49N which
have the N-glycosylation signal sequence (Asn-X-Ser) by the
substitution of glycine with asparagine at position 49 could
suppress the aggregation of amyloidogenic lysozymes ex-
pressed in yeast [9]. Both of the glycosylated amyloidogenic
lysozymes had similar secondary structures with non-glycosy-
lated types (I55T and D66H) and can be secreted in soluble
form to the medium [9]. To investigate the e¡ect of the quality
control system on the glycosylated amyloidogenic lysozymes,
we attempted to secrete glycosylated amyloidogenic lysozymes
I55T/G49N and D66H/G49N in wild-type and calnexin-dis-
rupted S. cerevisiae.
Recently Mori et al. [10] reported that, when unfolded pro-
teins are accumulated in the ER, an intracellular signaling
pathway termed the unfolded protein response (UPR) is acti-
vated to induce transcription of ER-localized molecular chap-
erones. It seems likely that we can estimate the accumulation
unfolding level of nascent protein from the induced concen-
tration of molecular chaperones. Therefore, this paper also
compares the concentration of molecular chaperones (BiP
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and PDI) in the ER when glycosylated amyloidogenic lyso-
zymes (I55T/G49N, D66H/G49N) are expressed in wild-type
and calnexin-disrupted S. cerevisiae.
2. Materials and methods
2.1. Materials
Restriction endonuclease, T4 DNA ligase, DNA sequencing kit and
DNA blunting kit were purchased from Takara Shuzo (Kyoto, Ja-
pan). The Quick Change1 site-directed mutagenesis kit was pur-
chased from Stratagene (Cambridge, MA, USA). Synthetic oligonu-
cleotides were purchased from Kurabo (Osaka, Japan). CM-
Toyopearl resin was a product of Toso (Tokyo, Japan).
2.2. Bacterial strains and plasmids
Escherichia coli XL-1 blue (recA1, endA1, gyrA96, thi-1, hsdR17,
supE44, relA1, lac (FP proAB, lacIqZ vM15, Tn10 (tetr)c), which was
used as a host cell in all cloning experiments, was supplied by Amer-
sham Japan. The S. cerevisiae diploid strain W303-1b (Mat a ade2-1
can1-100 ura3-1 leu2-3, 112 trp1-1 his3-11, 15) and W303-1b
v(cne1: :Leu2) were provided by Dr. Parlati, McGill University, Can-
ada. AH22 (Mat K, Leu, His4, Cir=3), used as another yeast expres-
sion strain of mutant lysozymes, was provided by Dr. I. Kumagai,
Tohoku University. S. cerevisiae strain AH22 v(cne1: :Leu2) was con-
structed in our previous study [5]. The recombinant plasmid pKK-1,
which contains a full-length hen egg white lysozyme cDNA, was pro-
vided by Dr. I. Kumagai, Tohoku University [11]. pYG100, an E.
coli-yeast shuttle vector, was provided by Dr. K. Matsubara of Osaka
University. The yeast episomal vectors pRS423 and pRS426 were
provided by Dr. R. Akada, Department of Applied Chemistry and
Chemical Engineering, Yamaguchi University.
2.3. Construction of S. cerevisiae W303-1b and AH22 expression
plasmids of the mutant hen lysozymes
The cDNAs of mutant lysozymes were inserted into the SalI site in
the pYG100 vector between the GPD promoter and terminator. The
pYG100 carrying mutant lysozyme genes was treated with HindIII.
Thus, a fragment (1.7 kb) was obtained from the promoter to the
terminator region containing the mutant hen lysozyme cDNA. By
using the blunt end approach, these fragments were inserted into
the multiclonal site of pRS426, the expression plasmid of yeast
S. cerevisiae W303-1b, and the multiclonal site of pRS423, the expres-
sion plasmid of yeast S. cerevisiae AH22.
2.4. Expression of the mutant lysozymes in S. cerevisiae W303-1b and
AH22
The expression vector was introduced into S. cerevisiae W303-1b
and AH22 by the lithium acetate procedure. The over-expressing sub-
clones with the highest levels of lysozyme activity were screened and
propagated from single colonies inoculated into 3 ml of yeast minimal
medium and incubated for 2 days at 30‡C with shaking. This precul-
ture was subcultured to 100 ml of the same medium in a £ask (500 ml)
and incubated another 2 days at 30‡C with shaking, and then 10 ml of
the second preculture was transferred to a fresh 1 l of the same
medium in a 3 l £ask and cultured under the same conditions [5].
2.5. Puri¢cation of the mutant hen lysozymes
The growth medium of the host cell was centrifuged at 7000 rpm
for 10 min at 4‡C. The supernatant was applied to a CM-Toyopearl
650M column (1.5U5.0 cm) equilibrated with 50 mM Tris^HCl bu¡er
(pH 7.5), and then adsorbed proteins were step-eluted using the same
bu¡er containing 0.5 M sodium chloride [12]. The fraction containing
the protein was collected, and then the samples which were desalted
and concentrated by Centricon centrifugal concentrators (Amicon,
USA) were used in the experiments.
2.6. Analysis of mRNA by competitive reverse transcriptase-polymerase
chain reaction
Analysis of BiP and PDI expression was performed using compet-
itive reverse transcriptase-polymerase chain reaction (RT-PCR) as de-
scribed by Siebert and Larrick [13]. A BiP-speci¢c primer pair (5P-
GCCCGCTGTAGAAGTAAGTG-3P and 5P-CTCTTGGTGCTG-
GTGGAATG-3P), yielding RT-PCR products of 1099 bp, and a
PDI-speci¢c primer pair (5P-ACGTTAAAGCCGCCGAGACT-3P
and 5P-CGTTGGCGTAGGTATCAGCT-3P), yielding RT-PCR
products of 1064 bp, were prepared based on the BiP and PDI
cDNA sequences of S. cerevisiae [14,15]. The internal standard
RNA was constructed as follows. 913 bp (for BiP) and 876 bp (for
PDI) homologous competitor mRNA fragments (a competitor that
has the same nucleotide sequences as the target RNA but contains
a deletion of about 200 bp), competing for the same set of primers,
were obtained as described using a competitive DNA construction kit
and a competitive RNA transcription kit [5].
Yeast transformants were cultured at 30‡C in 50 ml of selective
medium to the mid-log phase (OD600 = 1.5) and the harvest was col-
lected by centrifugation at 1000Ug for 5 min at 4‡C. Total yeast
RNA was isolated using RNeasy Mini Kits (Qiagen). 500 ng of total
RNA and 2U107 copies of competitive mRNA were co-converted
into ¢rst-strand cDNA using antisense-speci¢c primers. Subsequently,
equal portions of cDNA (a mixture of the target and a competitor)
were co-ampli¢ed by PCR with the BiP- or PDI-speci¢c primer pair.
The products were then resolved on a 1.5% agarose gel stained with
ethidium bromide. Because of the competition, the ratio of the
amounts of the two ampli¢ed products re£ects the ratio of the target
mRNA and RNA competitor. The amount of target mRNA is di-
rectly proportional to the log (At/Ac), where At is the amount of
ampli¢ed product from the target mRNA, and Ac is the amount of
ampli¢ed product from the competitor RNA. The densities of the
target and competitor band in the gel were determined with a Molec-
ular Imager (Bio-Rad, Japan) [5].
3. Results and discussion
3.1. Amyloidogenic mutant lysozymes I55T, D66H secreted at
a similar level in wild-type and calnexin-disrupted
S. cerevisiae
It was reported in our previous study that the disruption of
the calnexin gene did not lead to gross e¡ects at the level of
growth but led the yeast to decrease the quality control to
nascent glycoproteins in the ER [5]. The secretion amount
of mutant lysozyme I55T is much higher than that of mutant
D66H, although the secretion of amyloidogenic lysozymes is
extremely small in wild-type and calnexin-disrupted S. cerevi-
siae (Fig. 1). The disruption of calnexin has no e¡ect on the
secretion of non-glycosylated amyloidogenic mutant lyso-
zymes. The di¡erence between the secretion of mutants I55T
and D66H suggests that I55T mutant lysozyme may have a
more stable conformation than D66H so that it is di⁄cult to
Fig. 1. Secretion amounts of the amyloidogenic mutant lysozymes
I55T and D66H expressed in the wild-type (white columns) and cal-
nexin-disrupted (black columns) S. cerevisiae AH22. The vertical
bars indicate the standard deviation (n = 3).
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be aggregated after the secretion or to be degraded by the
quality control system in yeast.
3.2. Glycosylated amyloidogenic lysozyme I55T/G49N is
secreted at a similar level in the wild-type and
calnexin-deleted S. cerevisiae while mutant D66H/G49N
is secreted in calnexin-deleted strain much more than
in the wild-type strain
The secretion amounts of glycosylated amyloidogenic lyso-
zymes I55T/G49N and D66H/G49N were compared in the
expression system of wild-type and calnexin-deleted S. cerevi-
siae. Fig. 2 shows the secretion amounts of I55T/G49N and
D66H/G49N mutants in S. cerevisiae. The secretion amounts
of glycosylated amyloidogenic lysozymes were much higher
than those of the non-glycosylated amyloidogenic mutants
for the glycosylated chains masking the L-strand of amyloid-
ogenic lysozymes from the intermolecular cross-L-sheet asso-
ciation and then improving the solubility of amyloidogenic
lysozymes [9]. Interestingly, the secretion amounts of mutant
I55T/G49N were almost similar in both wild-type and calnex-
in-disrupted S. cerevisiae. In contrast, the secretion of mutant
D66H/G49N was greatly increased in calnexin-disrupted S.
cerevisiae, although the secretion was very low in the wild-
type strain. This was also con¢rmed by SDS^PAGE stained
for protein and carbohydrate with Coomassie brilliant blue
and 0.5% periodic acid^fuchsin solution, respectively (data
not shown). This strongly suggests that mutant lysozyme
I55T/G49N can release from the quality control of calnexin
in the ER while mutant D66H/G49N cannot.
3.3. BiP and PDI were induced at higher concentrations when
the glycosylated amyloidogenic lysozyme D66H/G49N are
secreted by wild-type and calnexin-disrupted S. cerevisiae
compared with mutant I55T/G49N
To investigate how the molecular chaperones located in the
ER are induced as a result of the accumulation of glycosylat-
ed amyloidogenic lysozymes I55T/G49N and D66H/G49N in
the ER, the mRNA concentrations of both molecular chaper-
ones BiP and PDI located in the ER were determined when
these lysozymes were expressed in wild-type and calnexin-dis-
rupted S. cerevisiae W303-1b. The results of the induction of
BiP and PDI are shown in Figs. 3 and 4, respectively. As a
control, the induction of BiP and PDI was investigated when
the stable glycosylated mutant lysozyme G49N was expressed
in S. cerevisiae W303-1b. There was only a small di¡erence in
the concentrations of BiP and PDI induced between that of
Fig. 2. Secretion amounts of the glycosylated amyloidogenic mutant
lysozymes I55T/G49N and D66H/G49N expressed in (a) the wild-
type (white columns) and calnexin-disrupted (black columns) S. ce-
revisiae AH22 and (b) wild-type (white columns) and calnexin-dis-
rupted (black columns) S. cerevisiae W303-1b. The vertical bars in-
dicate the standard deviation (n = 3).
Table 1
Comparison between glycosylated amyloidogenic mutants and other mutant lysozymes
Tad (‡C) Secretion
b BiPc PDIc
[wild] (Wg) [vcne] (Wg) [wild] [vcne] [wild] [vcne]
G49Nd 67.1 308.3 317.9 0.52 0.77 0.60 0.90
I55T/G49Ne 53.5 49.8 57.1 0.56 0.81 0.79 1.04
K13D/G49Nd 52.9 24.1 97.5 0.62 0.98 0.91 1.41
D66H/G49Ne 46.9 14.1 46.8 0.64 1.00 1.05 1.58
C76A/G49Nd 47.4 19.4 76.2 0.64 1.05 1.02 1.64
aTd (transition point of denaturation) was determined by the denaturation curves drawn by following changes in the ellipticity at 222 nm dur-
ing heating at 40‡C to 90‡C at pH 3.0.
bThe secretion amounts of mutant lysozymes in wild S. cerevisiae W303-1b [wild] or calnexin-disrupted S. cerevisiae W303-1b [vcne].
cThe relative mRNA levels of BiP/PDI by using quantitative analysis when the mutant lysozymes were secreted in wild-type and calnexin-dis-
rupted S. cerevisiae W303-1b.
dData from [5].
ePart of the data from [9].
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mutant lysozymes I55T/49N and G49N. In contrast, BiP and
PDI were induced in higher concentrations when the glycosy-
lated amyloidogenic lysozyme D66H/G49N was secreted in
wild-type and calnexin-disrupted S. cerevisiae W303-1b. This
unfolded protein response was markedly observed in the se-
cretion in the calnexin-disrupted strain. In a di¡erent yeast
strain, S. cerevisiae AH22, a similar observation was made
to that for S. cerevisiae W303-1b (data not shown). This ob-
servation strongly indicates that the conformation of mutant
lysozyme D66H/G49N was very unstable in the ER thus lead-
ing to the higher-level induction of ER molecular chaperones
via the UPR pathway. On the other hand, glycosylated amy-
Fig. 3. Quantitative analysis of BiP mRNA level when the glycosylated amyloidogenic mutant lysozymes were secreted by wild-type (CNE)
and calnexin-disrupted (CNE3) S. cerevisiae W303-1b. a: Electrophoresis of RT-PCR products separated in a 1.5% agarose gel was stained
with ethidium bromide. The 1099 bp products (upper) from yeast RNA and the 913 bp products (below) from BiP competitor RNA are indi-
cated. b: In order to quantitatively determine the mRNA levels, the intensities of the RT-PCR patterns were measured with a densitometer.
The graph shows the ratios of the density of the target band (upper) to that of the competitor band (lower) for calnexin-disrupted S. cerevisiae
(black columns) and wild-type S. cerevisiae (white columns). Dt, density of the band from target mRNA; Dc, density of the band from compet-
itor RNA.
Fig. 4. Quantitative analysis of PDI mRNA level when the glycosylated amyloidogenic mutant lysozymes were secreted by wild-type (CNE)
and calnexin-disrupted (CNE3) S. cerevisiae W303-1b. a: Electrophoresis of RT-PCR products separated in a 1.5% agarose gel was stained
with ethidium bromide. The 1064 bp products (upper) from yeast RNA and the 876 bp products (below) from PDI competitor RNA are indi-
cated. b: In order to quantitatively determine the mRNA levels, the intensities of the RT-PCR patterns were measured with a densitometer.
The graph shows the ratios of the density of the target band (upper) to that of the competitor band (lower) for calnexin-disrupted S. cerevisiae
(black columns) and wild-type S. cerevisiae (white columns). Dt, density of the band from target mRNA; Dc, density of the band from compet-
itor RNA.
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loidogenic lysozyme I55T/G49N seems to have a relatively
stable conformation which is not so di¡erent from that of
stable mutant G49N in the ER. Therefore mutant I55T/
G49N can release from the quality control of calnexin. This
is also supported by the similar secretion amounts of the mu-
tant lysozyme I55T/G49N between wild-type and calnexin-dis-
rupted S. cerevisiae.
3.4. Comparison of the secretion and induction of BiP and PDI
between glycosylated amyloidogenic mutants and
other mutant lysozymes
The unfolding transition midpoints for I55T/G49N and
D66H/G49N are 53.5‡C and 46.9‡C, which are similar to
those of mutant lysozymes K13D/G49N (52.9‡C, which desta-
bilizes K-helix 5^15) and C76A/G49N (47.4‡C, which lacks a
disul¢de bridge between cysteine 76 and 94), respectively. As
shown in Table 1, both the secretion amounts and induction
of BiP and PDI of mutant lysozymes K13D/G49N and C76A/
G49N were evidently enhanced in calnexin-disrupted S. cere-
visiae compared with those in wild-type strain [5]. This ten-
dency is similar to that of mutant D66H/G49N but di¡erent
from that of I55T/G49N. This suggested that mutant I55T/
G49N may have a speci¢c stable conformation in the ER,
which cannot be explained from the stability obtained by
thermal denaturation curves. Therefore, glycosylated mutant
amyloidogenic lysozyme I55T/G49N seems likely to release
from the quality control of calnexin with its stable conforma-
tion in the ER in wild-type S. cerevisiae, thus resulting in a
similar secretion amount as that in calnexin-disrupted strain.
On the other hand, the mutant D66H/G49N with its unstable
conformation in the ER must undergo the digestion pathway
via the quality control of calnexin, resulting in a very low
secretion amount, while the secretion was recovered in the
calnexin-disrupted strain without the quality control of cal-
nexin.
This paper proposes the possibility of the release of quality
control in the ER for glycosylated amyloidogenic lysozymes.
In S. cerevisiae, although the secreted form is polymannosy-
lated lysozyme with a large carbohydrate chain, it is sure that
the protein is glycosylated with a Glc1ÿ3Man8ÿ9GlcNAc2 ol-
igosaccharide chain in the ER [16,17]. It was recently reported
that this oligosaccharide chain functions as an anchor which
binds with the oligosaccharide moieties of calnexin and the
removal of the terminal mannose from the central branch of
oligosaccharide chain determines the fortune of nascent gly-
coproteins [18^20]. The detailed mechanism was not clear but
the mannose trimming seems likely to be dependent on the
folding manner of the polypeptide. Thus, it seems likely that
the glycosylated mutant amyloidogenic lysozyme I55T/G49N
can release from the quality control of calnexin in the ER with
the folded structure close to native lysozyme.
In our previous study, it was clear that both of the glyco-
sylated amyloidogenic lysozymes I55T/G49N and D66H/
G49N had similar secondary structures with non-glycosylated
types (I55T and D66H) [9]. It seems likely that amyloidogenic
mutant lysozyme I55T also has a relatively stable conforma-
tion in the ER. This suggests that mutant I55T may also
release from the normal quality control system in the ER
and then lead to amyloid disease. On the other hand, the
other amyloidogenic lysozyme, D66H, seems to be hard to
lead to amyloid disease in a cell with a normal ER quality
control system, because most of this mutant is degraded by
the quality control system in the ER due to its less stable
conformation. Therefore, this observation might give new
ideas on the mechanism of amyloidosis disease that the nor-
mal quality control system in the ER can rescue the cell from
molecular disease for mutant lysozyme D66H, but not for
mutant lysozyme I55T, despite similar amyloidogenic mutant
lysozymes.
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